RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 55 filers reported holding RAPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,964 | -19.1% | 4,691 | -9.0% | 0.05% | -17.5% |
| Q2 2023 | $96,361 | -4.6% | 5,153 | -6.4% | 0.06% | +1.8% |
| Q1 2023 | $100,980 | -33.1% | 5,503 | -27.8% | 0.06% | -29.1% |
| Q4 2022 | $150,975 | -10.7% | 7,625 | +8.7% | 0.08% | +17.9% |
| Q3 2022 | $169,000 | +33.1% | 7,015 | +0.7% | 0.07% | +42.6% |
| Q2 2022 | $127,000 | +13.4% | 6,964 | +37.0% | 0.05% | -6.0% |
| Q1 2022 | $112,000 | -43.4% | 5,082 | -5.7% | 0.05% | -33.3% |
| Q4 2021 | $198,000 | +20.0% | 5,389 | +1.4% | 0.08% | +2.7% |
| Q3 2021 | $165,000 | -7.3% | 5,312 | -5.0% | 0.07% | 0.0% |
| Q2 2021 | $178,000 | -35.3% | 5,589 | -54.9% | 0.07% | -37.1% |
| Q1 2021 | $275,000 | +14.6% | 12,381 | +1.9% | 0.12% | +16.0% |
| Q4 2020 | $240,000 | -47.9% | 12,155 | -15.1% | 0.10% | -58.7% |
| Q3 2020 | $461,000 | -2.3% | 14,317 | -12.0% | 0.24% | +8.0% |
| Q2 2020 | $472,000 | – | 16,274 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |